Cold leg in patient with high coated platelets: possible association with the use of rofecoxib.
Rashid
Abdul
A
University of Oklahoma, Oklahoma University Health Sciences Cente, Internal Medicine, Oklahoma City, Oklahoma, USA.
Dale
George
G
Hennebry
Thomas
T
D000208:Acute Disease; D001792:Blood Platelets / Q000187:drug effects* / Q000473:pathology; D003324:Coronary Artery Disease / Q000473:pathology; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D000077542:Eptifibatide; D005260:Female; D006801:Humans; D007511:Ischemia / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy; D007783:Lactones / Q000009:adverse effects*; D007866:Leg / Q000098:blood supply*; D023821:Limb Salvage; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D013450:Sulfones / Q000009:adverse effects*; D013927:Thrombosis / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy
D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D013450:Sulfones; C116926:rofecoxib; D000077542:Eptifibatide